Fluorinated Guanidino-Polyamine Conjugates with Ribonuclease Activity - Toward a Therapeutic Tool for Multi-Drug
Carola Romani1, Paola Gagni2, Riccardo Salvio3
1Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, via Mancinelli 7, Milano, 20131, Italy.
Researchers developed novel fluorinated guanidino-polyamine conjugates for gene therapy. These dual-function carriers efficiently deliver genes and degrade RNA, offering a promising strategy for multi-drug therapy and diagnostics.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Gene Therapy
Background:
- Developing multifunctional carriers is crucial for advanced therapeutics, especially for multi-drug therapy (MDT).
- Existing gene delivery systems face challenges in efficiency and multifunctionality.
Purpose of the Study:
- To synthesize and characterize novel fluorinated guanidino-polyamine conjugates for dual gene delivery and RNA degradation.
- To evaluate their potential as theranostic agents for combined diagnostics and MDT.
Main Methods:
- Synthesis of fluorinated guanidino-polyamine conjugates using polyamidoamine (PAMAM) dendrimers and polyethyleneimine (PEI).
- Potentiometric, kinetic, biolayer interferometry, and transfection studies to assess catalytic activity and gene delivery efficiency.
- 19F MRI for tracking capabilities.
Main Results:
- Conjugates demonstrated efficient DNA condensation and intracellular delivery.
- Proven mRNA cleavage activity, leading to reduced gene expression.
- High plasmid DNA (pDNA) delivery efficiency with low cytotoxicity, outperforming conventional PEI systems.
Conclusions:
- Low-generation PAMAM-derived conjugates exhibit potent artificial ribonuclease and gene delivery capabilities.
- These multifunctional carriers show promise for synergistic gene delivery and RNA degradation in MDT.
- The developed conjugates offer a novel strategy for combined diagnostic and therapeutic applications.
More Related Videos
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
10:33Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
Published on: April 25, 2025
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
